Bleichroeder LP Renovo Rx, Inc. Transaction History

Bleichroeder LP

  • $292 Million
  • Q1 2025

A detailed history of Bleichroeder LP transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Bleichroeder LP holds 500,000 shares of RNXT stock, worth $590,000. This represents 0.17% of its overall portfolio holdings.

Number of Shares
500,000
Holding current value
$590,000
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$0.91 - $1.51 $455,000 - $755,000
500,000 New
500,000 $495,000

About RenovoRx, Inc.

RNXT Quotes by TradingView
  • Ticker RNXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,066,860
  • Market Cap $10.7M
  • Description
  • RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...
More about RNXT
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email